For the first time, scientists have demonstrated how tanning beds cause fundamental DNA damage across almost the skin's ...

EADV experts urge clinicians to adjust examination techniques and lower biopsy thresholds to improve the diagnosis of ...

Schweiger Dermatology Group, one of the nation's fastest-growing and most comprehensive dermatology practices, today announced a landmark year of accelerated growth, innovation in skin cancer care, ...

The U.S. Food and Drug Administration (FDA) has approved Enhertu (fam-trastuzumab deruxtecan-nxki) in combination with ...

The U.S. Food and Drug Administration (FDA) have granted approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj), ...

Wrong site surgery is a “never event” that can be prevented by taking practical steps, according to a speaker at the American ...

In A Nutshell Swedish researchers found tattooed individuals had a 29% higher risk of melanoma compared to non-tattooed people, even after accounting for sun exposure and other known risk factors.

As Bha Bha Ba hits theatres worldwide, early Twitter reactions reveal what viewers are saying about Dileep’s performance, the ...

"Our veterans fought for our freedom; now they deserve hope and life-saving cancer care. No one who served should have to fight for cancer treatment or access to clinical trials," agreed Mel Mann, MBA ...

Progression free survival (PFS) of 74% at 16 months compares favourably to standard of care PFS of 50% at 11.5 months 1Strong PFS consistent ...

The symposium will present new research, including significant trials like HER2CLIMB-05, LidERA, and DESTINY-Breast11, through various sessions. SABCS 2025 will spotlight new advances in breast cancer ...

T-DXd plus pertuzumab improved quality-of-life outcomes, with fewer skin and mucosal symptoms but more gastrointestinal issues compared to the standard regimen. Both treatment arms showed similar pain ...